SCHEMBL805446

SCHEMBL805446

CCC(=O)N1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL299507 0.94
SCHEMBL11558147 0.92 L3MBTL1 (0.59)
Ammonia Solution, Strong SCHEMBL27829669 0.92 L3MBTL1 (0.56)
Hydrochloric Acid SCHEMBL5556862 0.92 L3MBTL1 (0.56)
SCHEMBL14518698 0.92 L3MBTL1 (0.59)
SCHEMBL765761 0.92 L3MBTL1 (0.59)
SCHEMBL18373854 0.92 L3MBTL1 (0.59)
SCHEMBL18373912 0.92 L3MBTL1 (0.59)
SCHEMBL21765879 0.92 L3MBTL1 (0.56)
Hydrochloric Acid SCHEMBL5552770 0.92 L3MBTL1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106536489-B Retinoid-related orphan receptor gamma modulators and uses thereof 葛兰素史密斯克莱知识产权发展有限公司 2020-02-07 CN claimed
EP-3148975-A1 NOVEL COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2017-04-05 EP claimed
WO-2015180612-A1 NOVEL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2015-12-03 WO claimed
US-20240051951-A1 BICYCLIC COMPOUND AND USE THEREOF SK BIOPHARMACEUTICALS CO., LTD. (KR) 2024-02-15 US disclosed
US-20230364277-A1 E-SELECTIN TARGETING AGENTS GLYCOMIMETICS, INC. (US) 2023-11-16 US disclosed
US-20230357177-A1 SYNTHESIS OF CANNABIDIOL AND ANALOGS THEREOF, AND RELATED COMPOUNDS, FORMULATIONS, AND METHODS OF USE NALU BIO, INC. 2023-11-09 US disclosed
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation C4 THERAPEUTICS, INC. (US) 2023-09-07 US disclosed
US-11725001-B2 Bicyclic compound and use thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2023-08-15 US disclosed
US-20230242514-A1 BICYCLIC INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS CORCEPT THERAPEUTICS INCORPORATED 2023-08-03 US disclosed
CN-116332961-A Substituted heteroaryl compounds, compositions and uses thereof 广东东阳光药业有限公司 2023-06-27 CN disclosed
US-20230151006-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2023-05-18 US disclosed
EP-1383501-B1 ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS MERCK & CO INC (US) 2007-04-04 EP disclosed
CN-1919937-A Method of using hollow sphere polymer ROHM AND HAAS FRANCE SAS (US) 2007-02-28 CN disclosed
US-20070004675-A1 Inhibitors of VEGF receptor and HGF receptor signaling METHYLGENE, INC. 2007-01-04 US disclosed
CN-1743343-A Method of using hollow sphere polymers ROHM & HAAS (US) 2006-03-08 CN disclosed
US-5045432-A Negative working lithography printing plates EASTMAN KODAK COMPANY (US) 1991-09-03 US disclosed
US-5043250-A Negative working; shelf life, image contrast EASTMAN KODAK COMPANY (US) 1991-08-27 US disclosed
US-4182743-A CARRIER CONTAINING HYDROGEN PEROXIDE WATER AND HYDROPHILIC STABILIZER PHILIP MORRIS INCORPORATED (US) 1980-01-08 US disclosed
US-4149941-A ELECTROLYTIC ALKOXYLATION HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-17 US disclosed
US-4118500-A Fungicidal alkoxy mono- and dialkoxy N-substituted cyclic amines HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed